Never-smoker (N) | Smoker (S) | COPD (C) | S vs. N | C vs. N | C vs. S | |
---|---|---|---|---|---|---|
n = 21 | n = 21 | n = 54 | p-value | p-value | p-value | |
mDC (% of leukocytes) | 0.19 [0.09-0.39] | 0.14 [0.05-0.27] | 0.15 [0.04-0.30] | <0.05 | <0.05 | 0.354 |
mDC (103/ml blood) | 12.4 [5.0-26.5] | 11.0 [3.5-29.2] | 10.9 [3.6-31.2] | 0.392 | 0.654 | 0.575 |
pDC (% of leukocytes) | 0.09 [0.04-0.25] | 0.08 [0.02-0.19] | 0.09 [0.02-0.22] | 0.595 | 0.740 | 0.749 |
pDC (103/ml blood) | 5.5 [2.8-15.4] | 7.0 [1.7-19.4] | 6.4 [1.5-16.9] | 0.227 | 0.145 | 0.680 |
ratio mDC/pDC | 1.9 [1.0-4.8] | 1.3 [0.7-3.6] | 1.7 [0.5-5.2] | 0.084 | 0.141 | 0.575 |
mDC surface markers | ||||||
BDCA-1 (% positive mDC) | 61 [37–87] | 67 [36–92] | 72 [34–94] | 0.505 | <0.05 | 0.101 |
BDCA-3 (% positive mDC) | 41 [14–77] | 68 [24–100] | 61 [20–99] | <0.001 | <0.001 | 0.516 |
CD54 (MFI) | 260 [177–373] | 251 [87–355] | 262 [160–445] | 0.651 | 0.354 | 0.097 |
CD86 (% positive mDC) | 24 [1–70] | 56 [6–77] | 44 [1–92] | <0.05 | <0.05 | 0.953 |
PD-L1 (% positive mDC) | 8 [0–31] | 11 [1–66] | 9 [0–41] | 0.529 | 0.925 | 0.286 |
CCR5 (% positive mDC) | 9 [0–63] | 12 [0–75] | 28 [0–91] | 0.191 | <0.01 | 0.200 |
OX40L (% positive mDC) | 9 [1–91] | 12 [0–32] | 16 [5–72] | 0.642 | <0.05 | <0.01 |
pDC surface markers | ||||||
CD54 (MFI) | 316 [181–480] | 351 [251–715] | 287 [0–698] | 0.406 | 0.124 | <0.05 |
PD-L1 (% positive pDC) | 35 [4–62] | 36 [9–73] | 23 [0–80] | 0.678 | < 0.05 | < 0.01 |